Osiris
Therapeutics, Inc. (NASDAQ: OSIR), today provided an update on the
status of the development and commercialization agreement with Genzyme,
a Sanofi company. On Wednesday, February 8, 2012, Sanofi issued a press
release, which included an update on their R&D pipeline, stating that it
...
read more